International Journal of Hematology · 2009 · 51 citations · 25 references
InflammationAngiogenesisMedicineApoptosisImmunologySp2/0 Myeloma CellsCell DeathEndothelial DysfunctionAnti-cancer AgentImmunotherapyPharmacologyCell BiologyOxidative StressNfκb P65
25
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Seema Singhal, Jayesh Mehta, Raman Desikan et al. · New England Journal of Medicine · 1999 · 2.6K citations · Full text
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
J. A. Child, Gareth J. Morgan, Faith E. Davies et al. · New England Journal of Medicine · 2003 · 1.8K citations · Full text
NF-κB as a Therapeutic Target in Multiple Myeloma
Teru Hideshima, Dharminder Chauhan, Paul G. Richardson et al. · Journal of Biological Chemistry · 2002 · 891 citations · Full text